Drug profile · INN
oxymorphone hydrochloride
OXYMORPHONE HYDROCHLORIDE
oxymorphone hydrochloride (OXYMORPHONE HYDROCHLORIDE) is a opioid receptors; mu/kappa/delta agonist. Associated with Teva Pharma GmbH. Route of administration: rectal. Current US regulatory status: approved.
Drug details — oxymorphone hydrochloride
- US status
- approved
- Class
- —
- Route
- RECTAL
- Patents
- 17
- Programs
- 0
- Data quality
- 0.89
Quick answer
oxymorphone hydrochloride (OXYMORPHONE HYDROCHLORIDE) is a opioid receptors; mu/kappa/delta agonist. Associated with Teva Pharma GmbH. Route of administration: rectal. Current US regulatory status: approved.
Key facts
Mechanism of action
Opioid receptors; mu/kappa/delta agonist
Primary target: Opioid receptors; mu/kappa/delta
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Related patents
-
US 12005054
Piperidinyl-3-(aryloxy)propanamides and propanoates
granted -
US 11045457
Piperidinyl-3-(aryloxy)propanamides and propanoates
granted -
US 10968213
Cyclopropanamine compound and use thereof
granted -
US 10414761
Cyclopropanamine compound and use thereof
granted -
US 10233142
Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide
granted -
US 10053456
Cyclopropanamine compound and use thereof
granted -
US 9920047
Cyclopropanamine compound and use thereof
granted -
US 9850199
Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide
granted -
US 9751885
Cyclopropanamine compound and use thereof
granted -
US 9718814
Cyclopropanamine compound and use thereof
granted -
US 9714241
Cyclopropanamine compound and use thereof
granted -
US 9617203
Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide
granted -
US 9487511
Cyclopropanamine compound and use thereof
granted -
US 9233165
Oligomer-aryloxy-substituted propanamine conjugates
granted -
US 9212129
Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide
granted -
US 8222218
Cyclopropanated carbohydrates
granted -
US 7759500
2-(N-methyl-propanamine)-3-(2-naphthol)thiophene, an impurity of duloxetine hydrochloride
granted
Frequently asked questions
What is oxymorphone hydrochloride?
oxymorphone hydrochloride (OXYMORPHONE HYDROCHLORIDE) is a opioid receptors; mu/kappa/delta agonist. Associated with Teva Pharma GmbH. Route of administration: rectal. Current US regulatory status: approved.
What is the brand name for oxymorphone hydrochloride?
OXYMORPHONE HYDROCHLORIDE is a marketed brand name for oxymorphone hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of oxymorphone hydrochloride?
oxymorphone hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.